NEW!

Myelofibrosis (MF) is a heterogeneous disorder with multiple characteristics dominated by the effects of progressive bone marrow fibrosis. The goal of this learning activity is to provide doctors with a review of MF.

Upon completing this module, participants will have a better understanding of its:

•  Epidemiology and pathophysiology

•  Clinical presentation

•  Diagnosis and prognosis

•  Path to referral

CPD reviewer:

Dr Haifa Kathrin Al-Ali, MD, PD

Associate Professor

Department of Haematology and Medical Oncology

University Hospital of Halle (Saale)

Germany

• Lecture

• Q&A session

Who should participate:

• Doctors

NOTE :

Please watch the video before attempting the assessment questions.

Terms & Conditions:

■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by: